Developer docs
API playgroundTry for free, no card

Search company profiles

Examedi

Full company profile

uuid0000xqd

Namestring
Examedi
Legal namestring
Examedi
Websiteurl
examedi.cl
Company typeenum
Private
Founded yearint
2021
Descriptiontext

Examedi is a Chilean digital health company founded in 2021 that operates an at-home healthcare services platform connecting patients to certified healthcare professionals for blood draws, laboratory testing, telemedicine consultations, and vaccinations. The platform serves individual consumers across Chile's Santiago Metropolitan Region (35 communes), Valparaíso, and Coquimbo, and has expanded into Mexico. Core products include Exámenes a Domicilio (at-home sample collection), Telemedicina (24/7 video consultations across general medicine and specialties), at-home vaccination (including the 2026 influenza campaign), medical order upload with automated quotation, and a biomarker dashboard tracking 100+ health indicators.

The underlying technology combines a self-serve booking and scheduling platform with integrations into Chile's healthcare reimbursement infrastructure: direct connections to all major ISAPREs (Colmena, Banmedica, Consalud, Cruz Blanca, Vida Tres), FONASA bonus processing, and a fintech partnership with Gokei for automatic one-click digital reimbursement. The company has developed a public price comparison tool benchmarking its exam pricing against traditional Chilean health centers, alongside a recently launched mobile application.

Examedi operates a hybrid B2C/B2B revenue model. Consumer revenue is generated per-test or per-consultation, with prices ranging from roughly $4,980 CLP for individual exams to over $421,200 CLP for comprehensive packs, and telemedicine starting at $25,000 CLP. The B2B motion targets corporate clients including Uber, Copec, Scotiabank, BancoEstado, LATAM, Pfizer, BUK, Fintual, and Chubb for employee wellness programs and on-site campaigns. Distribution combines self-serve online booking, WhatsApp-based customer support, healthcare provider partnerships (Clínica Alemana, Nueva Masvida via Imalab), and insurance-channel reselling (Caja Los Andes). The company is Y Combinator alumni (2021), closed a $17 million Series A led by General Catalyst in June 2022, and has cumulatively served more than 300,000 patients.

Short descriptiontext

Examedi is a Chilean digital health platform founded in 2021 that delivers at-home blood tests, telemedicine, vaccinations, and automatic ISAPRE reimbursement to individual patients and corporate clients across Chile and Mexico.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
51–100
akta.pro rankint
HeadquartersLas Condes, Chile
HQ citystring
Las Condes
HQ countrystring
Chile
HQ regionstring
Latin America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
at-home blood testing, telemedicine consultations, home healthcare services, health insurance reimbursement, mobile vaccination services
Industry1 code
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms
NAICS code3 codes
  • Medical Laboratories621511
  • Home Health Care Services62161
  • Offices of Physicians6211
SIC code3 codes
  • Services-Medical Laboratories8071
  • Services-Home Health Care Services8082
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
At-Home Healthcare Services
Social media profiles2 records
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model4 records
1At-Home Diagnostic Testing
TypeOne Time License
Description

Individual patients and corporate clients pay per examination or examination pack for at-home blood draws and laboratory tests. Prices range from approximately $4,980 CLP for basic tests like hemogram to over $421,200 CLP for comprehensive packs. The service is reimbursable by ISAPRE and bonifiable by FONASA, making it attractive to patients.

examedi.cl
2Telemedicine Consultations
TypeOne Time License
Description

Patients pay per telemedicine consultation starting from $25,000 CLP for general medicine. Consultations are bonificable with FONASA and reimbursable with ISAPRE and supplementary health insurance. Specialties offered include general medicine, psychiatry, psychology, dermatology, neurology, and child psychology.

examedi.cl
3Vaccination Services
TypeOne Time License
Description

Revenue from at-home vaccination services including influenza vaccines. Influenza vaccine 2026 starts from $16,890 CLP per person, with special pricing through partner insurers like Caja los Andes ($6,100 CLP per person for affiliated members). Additional services include Neurobion packages and other injectables.

examedi.cl
4Corporate/Enterprise Health Services
TypeSubscription Recurring
Description

B2B revenue stream providing employee health programs, on-site examination campaigns, and corporate vaccination programs. Enterprise clients displayed include Uber, Copec, Scotiabank, BancoEstado, BUK, and others, suggesting dedicated corporate sales engagement.

examedi.cl
Marketing channels8 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels6 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details6 tiers
1General Medicine Telemedicine Consultation
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Consultations start at $25,000 CLP. Bonificable with FONASA and reimbursable with ISAPRE and supplementary health insurance.

examedi.cl
2Specialist Telemedicine Consultations
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Specialist consultations (psychiatry, psychology, dermatology, neurology, child psychology) available through scheduled appointments at variable pricing.

examedi.cl
3Influenza Vaccine 2026
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Influenza vaccine 2026 at home starting from $16,890 CLP per person. Caja los Andes affiliates pay from $6,100 CLP per person. Neurobion pack of 3 injections + 3 home visits available for $54,990 (regular price $89,990).

examedi.cl
4Blood Examination Packs
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Individual exam pricing: Hemogram $4,980 CLP; Cholesterol Total $2,190 CLP; Perfil Bioquímico $14,080 CLP; Perfil Lipídico $10,030 CLP; Perfil Hepático $16,500 CLP. Comprehensive packs range from $12,600 CLP (urinary infection) to $421,200 CLP (36-allergen detection). ISAPRE patients receive FREE home visit on payments over $25,000 CLP.

examedi.cl
5Medical Order Upload and Quotation Service
ModelFreemiumBilling cadencePay-as-you-go
Notes

Uploading a medical order is free; Examedi provides a quotation for the required tests. The first two reimbursement management fees via Gokei are reportedly free for a limited time.

examedi.cl
6Price Comparison Engine
ModelFreemiumBilling cadencePay-as-you-go
Notes

The price comparison tool is free to use for all visitors, demonstrating Examedi's cost advantage. Data based on study conducted October 9, 2025.

examedi.cl
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Core offering1 text field

Examedi operates a digital healthcare platform that dispatches nurses and phlebotomists to patients' homes to collect samples for laboratory analysis, delivers those samples to partner labs, and returns results through a patient dashboard. The platform also provides 24/7 on-demand video telemedicine consultations with general practitioners and specialists, and offers at-home vaccination services with integrated automatic ISAPRE and FONASA insurance reimbursement.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 6 values shown
  • 300,000+ patients served since founding
+5 more records
Product overview1 text field

Examedi is a Chilean digital health platform offering a unified at-home healthcare services ecosystem. The core offerings are Exámenes a Domicilio (at-home blood and lab sample collection) and Telemedicina (24/7 online doctor consultations). These are complemented by vaccination at home, a medical order upload tool, an exam price comparison engine, a health blog, and a coverage checker. The platform integrates with Chilean health insurance systems for automatic reimbursement processing. Examedi serves individual patients and corporate clients (Examedi para Empresas) across the Santiago Metropolitan Region, Valparaíso, and Coquimbo in Chile.

Product and service3 records
1At-Home Blood and Laboratory Tests (Exámenes a Domicilio)
CategoryAt-home diagnostic services
Description

On-demand at-home blood draws and laboratory sample collection for Chilean patients; a mobile nurse or phlebotomist visits the patient's home, transports samples to a partner lab, and results are returned through the Examedi patient dashboard with automatic ISAPRE/FONASA reimbursement processing.

224/7 Telemedicine Consultations (Telemedicina)
CategoryTelemedicine
Description

On-demand video consultations with general practitioners and specialists available 24/7 through Examedi's platform, enabling Chilean patients to receive remote medical advice, prescriptions, and referrals without traveling to a clinic.

3At-Home Vaccination Service (Vacunación a Domicilio)
CategoryAt-home preventive care
Description

At-home administration of vaccines by Examedi healthcare staff, including influenza and COVID-19 vaccines, distributed through compensation fund partners (e.g., Caja Los Andes) and direct consumer channels with automatic ISAPRE reimbursement.

Scale indicator8 records

Each record includes

Type, Value, Description, Source

Partnership9 partners
Strategic tierCoreTypeTechnology or IntegrationAnnounced on2025-02-24
Description

Strategic fintech partnership with Gokei, a Chilean fintech specializing in reimbursement automation. The integration enables automatic digital processing of ISAPRE and supplementary health insurance reimbursements with a single click at checkout. The platform sends information directly to the patient's ISAPRE or insurer, managing the entire process digitally without forms, receipts, photos, or emails. Examedi is offering the first two management fees free for a limited time. This collaboration establishes a new standard in digital health in Chile.

2Nueva Masvida (via Imalab)
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2022-08-03
Description

Strategic alliance through Imalab laboratory benefiting over 400,000 Nueva Masvida affiliates. Examedi provides at-home diagnostic services to the insured member base, extending access to convenient healthcare while strengthening Nueva Masvida's digital health offerings.

examedi.cl
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Strategic partnership with Clínica Alemana, one of Chile's leading healthcare institutions, to reinforce digital strategy and at-home diagnostic services. Clínica Alemana endorsed Examedi as a digital health partner, leveraging Examedi's at-home testing capabilities to extend its digital health reach.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Colmena ISAPRE enabling automatic digital reimbursement processing for Colmena beneficiaries. Examedi's platform integrates directly with Colmena's systems for seamless reimbursement workflow, eliminating patient paperwork.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Banmedica ISAPRE enabling automatic digital reimbursement processing for Banmedica beneficiaries through the Gokei-powered integration.

6Consalud
Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Consalud ISAPRE enabling automatic digital reimbursement processing for Consalud beneficiaries through the integrated platform.

examedi.cl
Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Cruz Blanca ISAPRE enabling automatic digital reimbursement processing for Cruz Blanca beneficiaries through the integrated digital reimbursement platform.

Strategic tierCoreTypeTechnology or Integration
Description

Partnership with Vida Tres ISAPRE enabling automatic digital reimbursement processing for Vida Tres beneficiaries through the integrated platform.

9Caja Los Andes
Strategic tierCoreTypeChannel Partner/ Reseller/ Distributor
Description

Corporate and distribution partnership with Caja Los Andes, a major Chilean health insurance fund. Caja Los Andes promotes Examedi's at-home influenza vaccination service to its affiliated members at discounted pricing ($6,100 CLP per person). Examedi appears as a preferred provider on Caja Los Andes' platform via sdk.examedi.com/cla-influenza-2026.

examedi.cl
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

US-based at-home lab testing platform offering direct-to-consumer diagnostics with physician-reviewed results and insurance integration. Highly comparable to Examedi's at-home blood draw and biomarker interpretation offering, with a similar marketplace-style model.

TypeDirect peer
Description

Global at-home diagnostics and telehealth company providing self-collected lab tests with nurse-led services and physician consultations. Closest direct comparable to Examedi's integrated at-home diagnostics + telemedicine + result delivery stack.

3Ro
TypeBroad incumbent
Description

US-based direct-to-patient telehealth and at-home diagnostics platform covering primary care, specialty care, and lab testing. Comparable integrated virtual-care-plus-diagnostics model; operates at significantly larger scale and broader service breadth than Examedi.

TypeOthers
Description

Provider of at-home telehealth examination devices and remote examination kits enabling clinicians to perform guided virtual exams. Adjacent enabling technology for home-based clinical services, complementary to Examedi's home-visit diagnostic and telemedicine offerings.

TypeDirect peer
Description

Brazilian healthtech offering rapid at-home and point-of-care laboratory testing with digital results delivery. Closest LATAM-region peer to Examedi in terms of at-home diagnostic service model and pricing transparency.

6Medismart
TypeDirect peer
Description

Chilean telemedicine and home-care healthtech operating in the same domestic market as Examedi. Comparable in providing remote consultations and home-based services to Chilean consumers and insurers, and competes for the same ISAPRE-integrated demand.

TypeEmerging player
Description

Brazilian outpatient healthcare marketplace offering consultations, exams, and procedures at transparent prices to consumers and corporates. Comparable in price-transparent, consumer-facing healthcare model targeting under-served middle-class demand, similar to Examedi's value proposition in Chile.

8Sami
TypeEmerging player
Description

Brazilian healthtech offering affordable employer-sponsored health plans with embedded telemedicine and digital care delivery. Comparable LATAM healthtech combining insurer/payer relationships, virtual care, and B2B2C distribution — similar GTM pattern to Examedi's corporate wellness motion.

TypeEmerging player
Description

Brazilian low-cost laboratory testing chain offering affordable blood work and diagnostic exams. Comparable in undercutting traditional lab pricing and offering a streamlined, consumer-friendly diagnostic experience — a similar value proposition in a larger adjacent LATAM market.

TypeBroad incumbent
Description

Large US telehealth and consumer health company combining virtual consultations with at-home diagnostics, prescription delivery, and recurring wellness subscriptions. Broader portfolio than Examedi but operating the same integrated virtual-care-plus-at-home diagnostics thesis at much larger scale.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat5 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers19 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile2 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds8 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Examedi

At-Home Healthcare Servicesexamedi.cl

Examedi is a Chilean digital health platform founded in 2021 that delivers at-home blood tests, telemedicine, vaccinations, and automatic ISAPRE reimbursement to individual patients and corporate clients across Chile and Mexico.

What Examedi does

Examedi is a Chilean digital health company founded in 2021 that operates an at-home healthcare services platform connecting patients to certified healthcare professionals for blood draws, laboratory testing, telemedicine consultations, and vaccinations. The platform serves individual consumers across Chile's Santiago Metropolitan Region (35 communes), Valparaíso, and Coquimbo, and has expanded into Mexico. Core products include Exámenes a Domicilio (at-home sample collection), Telemedicina (24/7 video consultations across general medicine and specialties), at-home vaccination (including the 2026 influenza campaign), medical order upload with automated quotation, and a biomarker dashboard tracking 100+ health indicators.

The underlying technology combines a self-serve booking and scheduling platform with integrations into Chile's healthcare reimbursement infrastructure: direct connections to all major ISAPREs (Colmena, Banmedica, Consalud, Cruz Blanca, Vida Tres), FONASA bonus processing, and a fintech partnership with Gokei for automatic one-click digital reimbursement. The company has developed a public price comparison tool benchmarking its exam pricing against traditional Chilean health centers, alongside a recently launched mobile application.

Examedi operates a hybrid B2C/B2B revenue model. Consumer revenue is generated per-test or per-consultation, with prices ranging from roughly $4,980 CLP for individual exams to over $421,200 CLP for comprehensive packs, and telemedicine starting at $25,000 CLP. The B2B motion targets corporate clients including Uber, Copec, Scotiabank, BancoEstado, LATAM, Pfizer, BUK, Fintual, and Chubb for employee wellness programs and on-site campaigns. Distribution combines self-serve online booking, WhatsApp-based customer support, healthcare provider partnerships (Clínica Alemana, Nueva Masvida via Imalab), and insurance-channel reselling (Caja Los Andes). The company is Y Combinator alumni (2021), closed a $17 million Series A led by General Catalyst in June 2022, and has cumulatively served more than 300,000 patients.

Examedi firmographics

Firmographics
Name
Examedi
Legal name
Examedi
Website
https://examedi.cl
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
51–100 employees
Short description
Examedi is a Chilean digital health platform founded in 2021 that delivers at-home blood tests, telemedicine, vaccinations, and automatic ISAPRE reimbursement to individual patients and corporate clients across Chile and Mexico.
Ownership category
akta.pro rank

Examedi industry classification

Industry
Product category
At-Home Healthcare Services
NAICS
Medical Laboratories (621511), Home Health Care Services (62161), Offices of Physicians (6211)
SIC
Services-Medical Laboratories (8071), Services-Home Health Care Services (8082), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLALAAAE
At-Home Lab Testing & Diagnostics-Integrated Virtual Care
Healthcare & Life Sciences/Telehealth Platforms/Direct-to-Consumer Virtual Care Platforms

Keywords

  • At-home blood testing
  • Telemedicine consultations
  • Home healthcare services
  • Health insurance reimbursement
  • Mobile vaccination services

Where Examedi is headquartered

Location

Headquarters

HQ city
Las Condes
HQ country
Chile
HQ region
Latin America

Offices2 records

Markets served

Examedi business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. At-Home Diagnostic Testing: Individual patients and corporate clients pay per examination or examination pack for at-home blood draws and laboratory tests. Prices range from approximately $4,980 CLP for basic tests like hemogram to over $421,200 CLP for comprehensive packs. The service is reimbursable by ISAPRE and bonifiable by FONASA, making it attractive to patients.
  2. Telemedicine Consultations: Patients pay per telemedicine consultation starting from $25,000 CLP for general medicine. Consultations are bonificable with FONASA and reimbursable with ISAPRE and supplementary health insurance. Specialties offered include general medicine, psychiatry, psychology, dermatology, neurology, and child psychology.
  3. Vaccination Services: Revenue from at-home vaccination services including influenza vaccines. Influenza vaccine 2026 starts from $16,890 CLP per person, with special pricing through partner insurers like Caja los Andes ($6,100 CLP per person for affiliated members). Additional services include Neurobion packages and other injectables.
  4. Corporate/Enterprise Health Services: B2B revenue stream providing employee health programs, on-site examination campaigns, and corporate vaccination programs. Enterprise clients displayed include Uber, Copec, Scotiabank, BancoEstado, BUK, and others, suggesting dedicated corporate sales engagement.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goGeneral Medicine Telemedicine Consultation
Unit PricingPay-as-you-goSpecialist Telemedicine Consultations
Unit PricingPay-as-you-goInfluenza Vaccine 2026
Unit PricingPay-as-you-goBlood Examination Packs
FreemiumPay-as-you-goMedical Order Upload and Quotation Service
FreemiumPay-as-you-goPrice Comparison Engine

Go-to-market motion2 records

Distribution channels6 records

Marketing channels8 records

Examedi product offering

Product offering

Core offering

Examedi operates a digital healthcare platform that dispatches nurses and phlebotomists to patients' homes to collect samples for laboratory analysis, delivers those samples to partner labs, and returns results through a patient dashboard. The platform also provides 24/7 on-demand video telemedicine consultations with general practitioners and specialists, and offers at-home vaccination services with integrated automatic ISAPRE and FONASA insurance reimbursement.

Product overview

Examedi is a Chilean digital health platform offering a unified at-home healthcare services ecosystem. The core offerings are Exámenes a Domicilio (at-home blood and lab sample collection) and Telemedicina (24/7 online doctor consultations). These are complemented by vaccination at home, a medical order upload tool, an exam price comparison engine, a health blog, and a coverage checker. The platform integrates with Chilean health insurance systems for automatic reimbursement processing. Examedi serves individual patients and corporate clients (Examedi para Empresas) across the Santiago Metropolitan Region, Valparaíso, and Coquimbo in Chile.

Differentiator

Problem solved

Functional benefit

Products and services

  • At-Home Blood and Laboratory Tests (Exámenes a Domicilio) On-demand at-home blood draws and laboratory sample collection for Chilean patients; a mobile nurse or phlebotomist visits the patient's home, transports samples to a partner lab, and results are returned through the Examedi patient dashboard with automatic ISAPRE/FONASA reimbursement processing.
  • 24/7 Telemedicine Consultations (Telemedicina) On-demand video consultations with general practitioners and specialists available 24/7 through Examedi's platform, enabling Chilean patients to receive remote medical advice, prescriptions, and referrals without traveling to a clinic.
  • At-Home Vaccination Service (Vacunación a Domicilio) At-home administration of vaccines by Examedi healthcare staff, including influenza and COVID-19 vaccines, distributed through compensation fund partners (e.g., Caja Los Andes) and direct consumer channels with automatic ISAPRE reimbursement.

Quantifiable outcome

  • 300,000+ patients served since founding
  • +5 more outcomes

Companies that use Examedi

Customer profile

Named customers19 records

Segments3 records

Ideal customer profiles2 records

Examedi technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Examedi partnerships and signals

Strategic signal

Partnerships

Nine partnerships are on record, tiered core.

  • GokeicoreTechnology or Integration · 24 February 2025Strategic fintech partnership with Gokei, a Chilean fintech specializing in reimbursement automation. The integration enables automatic digital processing of ISAPRE and supplementary health insurance reimbursements with a single click at checkout. The platform sends information directly to the patient's ISAPRE or insurer, managing the entire process digitally without forms, receipts, photos, or emails. Examedi is offering the first two management fees free for a limited time. This collaboration establishes a new standard in digital health in Chile.
  • Nueva Masvida (via Imalab)coreStrategic or Co-development Partner · 3 August 2022Strategic alliance through Imalab laboratory benefiting over 400,000 Nueva Masvida affiliates. Examedi provides at-home diagnostic services to the insured member base, extending access to convenient healthcare while strengthening Nueva Masvida's digital health offerings.
  • Clínica AlemanacoreStrategic or Co-development PartnerStrategic partnership with Clínica Alemana, one of Chile's leading healthcare institutions, to reinforce digital strategy and at-home diagnostic services. Clínica Alemana endorsed Examedi as a digital health partner, leveraging Examedi's at-home testing capabilities to extend its digital health reach.
  • ColmenacoreTechnology or IntegrationPartnership with Colmena ISAPRE enabling automatic digital reimbursement processing for Colmena beneficiaries. Examedi's platform integrates directly with Colmena's systems for seamless reimbursement workflow, eliminating patient paperwork.
  • BanmedicacoreTechnology or IntegrationPartnership with Banmedica ISAPRE enabling automatic digital reimbursement processing for Banmedica beneficiaries through the Gokei-powered integration.
  • ConsaludcoreTechnology or IntegrationPartnership with Consalud ISAPRE enabling automatic digital reimbursement processing for Consalud beneficiaries through the integrated platform.
  • Cruz BlancacoreTechnology or IntegrationPartnership with Cruz Blanca ISAPRE enabling automatic digital reimbursement processing for Cruz Blanca beneficiaries through the integrated digital reimbursement platform.
  • Vida TrescoreTechnology or IntegrationPartnership with Vida Tres ISAPRE enabling automatic digital reimbursement processing for Vida Tres beneficiaries through the integrated platform.
  • Caja Los AndescoreChannel Partner/ Reseller/ DistributorCorporate and distribution partnership with Caja Los Andes, a major Chilean health insurance fund. Caja Los Andes promotes Examedi's at-home influenza vaccination service to its affiliated members at discounted pricing ($6,100 CLP per person). Examedi appears as a preferred provider on Caja Los Andes' platform via sdk.examedi.com/cla-influenza-2026.

Scale indicators8 records

Recent moves6 records

Expansion highlights6 records

Examedi competitors and assessment

Company assessment

Direct peers

  • Everlywell: US-based at-home lab testing platform offering direct-to-consumer diagnostics with physician-reviewed results and insurance integration. Highly comparable to Examedi's at-home blood draw and biomarker interpretation offering, with a similar marketplace-style model.
  • LetsGetChecked: Global at-home diagnostics and telehealth company providing self-collected lab tests with nurse-led services and physician consultations. Closest direct comparable to Examedi's integrated at-home diagnostics + telemedicine + result delivery stack.
  • Hilab: Brazilian healthtech offering rapid at-home and point-of-care laboratory testing with digital results delivery. Closest LATAM-region peer to Examedi in terms of at-home diagnostic service model and pricing transparency.
  • Medismart: Chilean telemedicine and home-care healthtech operating in the same domestic market as Examedi. Comparable in providing remote consultations and home-based services to Chilean consumers and insurers, and competes for the same ISAPRE-integrated demand.

Broad incumbents

  • Ro: US-based direct-to-patient telehealth and at-home diagnostics platform covering primary care, specialty care, and lab testing. Comparable integrated virtual-care-plus-diagnostics model; operates at significantly larger scale and broader service breadth than Examedi.
  • Hims & Hers Health: Large US telehealth and consumer health company combining virtual consultations with at-home diagnostics, prescription delivery, and recurring wellness subscriptions. Broader portfolio than Examedi but operating the same integrated virtual-care-plus-at-home diagnostics thesis at much larger scale.

Others

  • TytoCare: Provider of at-home telehealth examination devices and remote examination kits enabling clinicians to perform guided virtual exams. Adjacent enabling technology for home-based clinical services, complementary to Examedi's home-visit diagnostic and telemedicine offerings.

Emerging players

  • dr.consulta: Brazilian outpatient healthcare marketplace offering consultations, exams, and procedures at transparent prices to consumers and corporates. Comparable in price-transparent, consumer-facing healthcare model targeting under-served middle-class demand, similar to Examedi's value proposition in Chile.
  • Sami: Brazilian healthtech offering affordable employer-sponsored health plans with embedded telemedicine and digital care delivery. Comparable LATAM healthtech combining insurer/payer relationships, virtual care, and B2B2C distribution — similar GTM pattern to Examedi's corporate wellness motion.
  • Labi Exames: Brazilian low-cost laboratory testing chain offering affordable blood work and diagnostic exams. Comparable in undercutting traditional lab pricing and offering a streamlined, consumer-friendly diagnostic experience — a similar value proposition in a larger adjacent LATAM market.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Examedi social profiles

Digital presence

Examedi financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Examedi leadership team

Management profile

Number of profiles

Profiles3 records

Examedi funding detail

Funding detail

Funding overview

Funding rounds8 records

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Examedi M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Examedi

What does Examedi do?

Examedi operates a digital healthcare platform that dispatches nurses and phlebotomists to patients' homes to collect samples for laboratory analysis, delivers those samples to partner labs, and returns results through a patient dashboard. The platform also provides 24/7 on-demand video telemedicine consultations with general practitioners and specialists, and offers at-home vaccination services with integrated automatic ISAPRE and FONASA insurance reimbursement.

Is Examedi a public or private company?

Examedi is a private company. It is classified as venture growth investor backed and is currently operating.

When was Examedi founded?

Examedi was founded in 2021. It employs 51 to 100 people.

Where is Examedi based?

Examedi is headquartered in Las Condes, Chile, in the Latin America region.

How does Examedi make money?

Four revenue lines are on record. At-Home Diagnostic Testing is the primary driver. The others are telemedicine Consultations, vaccination Services and corporate/Enterprise Health Services.

Who are Examedi's main competitors?

Direct peers on record are Everlywell, LetsGetChecked, Hilab and Medismart. Broad incumbents are Ro and Hims & Hers Health. TytoCare is listed as an others. Emerging players are dr.consulta, Sami and Labi Exames.

Does Examedi have an API?

No public API is recorded for Examedi.

What industry is Examedi in?

Examedi's product category is At-Home Healthcare Services. Its primary akta.pro industry code is HLALAAAE, At-Home Lab Testing & Diagnostics-Integrated Virtual Care. Its NAICS code is 621511 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Startup ResearcherExamedi Raises $750K for Profitable Growth in LatAmChilean healthtech company Examedi has secured $750,000 in a funding round led by Platanus, with the full exit of U.S. fund General Catalyst, marking a significant reshaping of the company's investor base. The round values Examedi at $17 million, approximately 80 percent below its previous peak, reflecting the broader market correction and the company's strategic pivot toward sustainable, profitability-focused growth. Under new CEO Mariano Werner, the company has reduced its headcount from 160 to 26 and is now targeting 50 to 60 percent annual growth while consolidating operations in Mexico and Chile.LatamlistExamedi raises $750K in a round led by PlatanusChilean healthtech startup Examedi raised $750,000 in a funding round led by Platanus, with participation from existing board members and General Catalyst exiting its position in the company. The company, which provides at-home diagnostic services through a digital platform covering scheduling to test results delivery, plans to use the funds to enhance operational efficiency and expand its presence in Mexico and Chile. CEO Mariano Werner outlined a private-equity-style growth strategy prioritizing profitability and efficient growth of 50-60% annually over aggressive expansion.Diario FinancieroLa healthtech chilena que quiere acercar la salud a 100 millones de personasMedismart, a Chilean healthtech company, raised US$6 million last year from the Benslie International fund, linked to the Weinsman family, and is preparing a new funding round of US$30 million to expand operations in Mexico and Colombia. The company currently serves 3 million users, performs 1,500 daily consultations, and projects 2022 revenue of US$6 million, up from US$1 million in 2021, having sold US$500,000 in the past month alone. Medismart operates a B2B digital health ecosystem offering telemedicine, prescription delivery, and at-home medical exams through partnerships with startups such as Examedi and Yapp.SecSEC FORM DExamedi Holdings Ltd filed a Form D with the U.S. Securities and Exchange Commission for an exempt securities offering totaling $22,499,000 under Rule 506(b). The filing indicates that all offered securities have been sold to 41 investors, including the conversion of outstanding convertible securities.ExamediExamedi Raises $17M in Series A Funding to Improve LATAM Healthcare - ExamediExamedi, a provider of at-home medical testing services, closed a $17 million Series A funding round led by General Catalyst to expand its operations in Latin America. The company utilizes food-delivery logistics to match patients with nurses for home-based lab sample collection, aiming to reduce costs and improve healthcare accessibility in the region. Examedi plans to use the capital for product development and geographic expansion into new cities across Chile and Mexico.TechloyChilean healthtech startup Examedi raises $17 million in fundingChilean healthtech startup Examedi raised $17 million in a Series A funding round led by General Catalyst. The capital will support product development with a focus on B2B solutions and expand its operations in Chile and Mexico. Previous investors including Thomas Srougi, Sebastian Mejia, and Jamie Karraker also participated in the round.Startups LatamExamedi, la startup chilena fundada por emprendedores Gen Z, cierra ronda por US$ 2 millones • Startups Chilenas de exportaciónExamedi, a Chilean startup founded by Gen Z entrepreneurs, closed a $2 million seed round with participation from 8VC, Quiet Capital, and others. The company plans to expand into Mexico and Colombia, targeting 2,000 monthly patients by year-end and $60,000 in December revenue.ContxtoChilean health marketplace Examedi raises $2.7M to grow internationallyChilean healthcare marketplace Examedi raised $2.7 million in a seed round led by investors 8VC, Quiet Capital, and Goodwater Capital to expand its home-based medical testing services. The company plans to enter the Mexican market by the end of the year, aiming to process 5,000 monthly patients across both countries while launching prescription delivery services.Startups LatamTres chilenas cuentan cómo se preparan para el demo day de YC y sus planes tras pasar por la aceleradora más importante del mundo • Startups Chilenas de exportaciónSeven Chilean startups, including Examedi, Encuadrado, and Instacrops, are preparing for Y Combinator's demo day on August 31 and September 1. Examedi closed a $1 million round, while the others aim to raise capital for growth. The batch marks Chile's most representation in YC from South America.Startups LatamNuevo récord: siete nuevas startups locales son parte del último batch de YC • Startups Chilenas de exportaciónSeven new Chilean startups—Instacrops, Cero, Rendalo Maq, Toku, Chipax, and Examedi—joined Y Combinator's S21 batch, surpassing last year's four. The companies are preparing for a demo day on August 31 and September 1. Investors and the ACVC see this as a positive trend for Chile's startup ecosystem.